Aurobindo Pharma reports over four fold jump in Q3 consolidated net profit

07 Feb 2014 Evaluate

Aurobindo Pharma has reported results for third quarter ended December 31, 2013.

The company has reported over two fold jump in its net profit at Rs 418.16 crore for the quarter as compared to Rs 144.28 crore for the same quarter in the previous year. Total income of the company increased by 33.41% at Rs 1911.08 crore for quarter under review as compared to Rs 1432.45 crore for the quarter ended December 31, 2012.

On the consolidated basis, the group has reported over four fold jump  in its net profit after taxes and Minority Interest at Rs 417.49 crore for the quarter as compared to Rs 91.81 crore for the same quarter in the previous year. Total income of the group has increased by 36.07% at Rs 2144.12 crore for quarter under review as compared to Rs 1575.73 crore for the quarter ended December 31, 2012.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×